期刊文献+

组胺受体1和2拮抗药对神经病理性疼痛的疗效

Efficiency of histamine H_1 and H_2 receptor antagonists on neuropathic pain in rats
下载PDF
导出
摘要 目的探讨脑室内注射组胺受体拮抗药对神经病理性疼痛大鼠的治疗作用。方法选择左侧坐骨神经部分结扎致神经病理性疼痛大鼠30只,随机均分为五组。对照组(C组)脑室内注射生理盐水;P1、P2组分别注射组胺受体1拮抗药美吡拉敏1.5μg和15μg;R1、R2组注射组胺受体2拮抗药雷尼替丁10μg和100μg,评价注药后痛阈的改变。结果与C组相比,R1、R2组雷尼替丁能显著提高大鼠对机械性刺激的痛阈(P<0.05);且R2组对疼痛的治疗效果加强,时间延长。结论神经病理性疼痛时,采用组胺受体2拮抗药能提高痛阈,缓解疼痛。 Objective To investigate the efficiency of intracerebroventricular injection of histamine receptor antagonists on mechanical pain threshold of neuropathic pain in rats. Methods The neuropathic pain rat model was established by partially ligation of the sciatic nerve in 30 rats. Two weeks later, histamine receptor 1 antagonist pyrilamine 1.5μg or 15μg was injected intracerebroventricularly in group P1 or P2 ,histamine receptor 2 antagonist ranitidine 10μg or 100μg in group R1 or R2, and normal saline in group C as the control. The pain threshold was measured. Results Compaered with group C, the pain threshold was signifigantly increased in group R1 and R2, especially in group R2 (P〈0. 05). Conclusion Histamine H2 receptor antagonist can increase pain threshold in rats with neuropathic pain.
作者 黄亮 長櫓巧
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2009年第5期421-423,共3页 Journal of Clinical Anesthesiology
基金 日本笹川医学研究者第28届资助项目
关键词 组胺受体拮抗药 神经病理性疼痛 临床 疗效 Histamine antagonists Neuropathic pain
  • 相关文献

参考文献9

  • 1黄亮,足立尚登,长橹巧,新井达.神经病理性疼痛大鼠纹状体组胺水平的变化及脑室内注射组胺的效果[J].中华麻醉学杂志,2006,26(6):542-546. 被引量:4
  • 2Seltzer Z,Dubner R,Shir Y.A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.Pain,1990,43:205-218.
  • 3Haas H,Panula P.The role of histamine and the tuberomamillary nucleus in the nervous system.Nat Rev Neurosci,2003,4:121-130.
  • 4Galeotti N,Malmberg-Aiello P,Bartolini A,et al.H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway.Neuropharmacology,2004,47:295-303.
  • 5Mobarakeh JI,Sakurada S,Katsuyama S,et al.Role of histamine H(1) receptor in pain perception:a study of the receptor gene knockout mice.Eur J Pharmacol,2000,391:81-89.
  • 6Suzuki R,Edwards M,Dickenson AH.ReN-1869[(R)-1-(3-(10,11-dihydro-5 H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)-3-piperid ine carboxylic acid],a novel histamine H1 receptor antagonist,produces potent and selective antinociceptive effects on dorsal horn neurons after inflammation and neuropathy.J Pharmacol Exp Ther,2004,309:1230-1238.
  • 7Suzuki R,Dickenson AH.Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury,Exp Neurol,2006,198:72-80.
  • 8Farzin D,Asghari L,Nowrouzi M.Rodent antinocieeption following acute treatment with different histamine receptor agonists and antagonists.Pharmacol Biochem Behav,2002,72:751-760.
  • 9Mobarakeh JI,Takahashi K,Sakurada S,et al.Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice.Neuropharmacology,2006,51:612-622.

二级参考文献10

  • 1Gherlardini C, Galeotti N, Bartolini A. No development of tolerance to analgesia by repeated administration of H1 antagonists. Life Sci, 1998,63 : 317-322.
  • 2Malmberg Aiello P. Lamberti C, Ghelardini C. et al. Role of histamine in rodent antinociception. Br J Pharmaeol, 1994,111: 1269-1279.
  • 3Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain,1990,43: 205-218.
  • 4Itoh Y, Oishi R, Adachi N, et al. A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization:its application to hiological specimens. J Neurechem, 1992, 58: 884-889.
  • 5Chaplan SR, Bach FW, Pogrel JW. et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994,53:55-63.
  • 6Adachi N, Itoh Y, Oishi R. et al. Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion. J Cereb Blood Flow Metab,1992,12:477-483.
  • 7Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci, 2003,4: 121-130.
  • 8Horton JR, Sawada K, Nishibori M, et al. Structural basis for inhibition of histamine N-methyltransferase by diverse drug. J Mol Biol, 2005,353:334-344.
  • 9Duch DS, Bowers SW, Nichol CA. Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase. Biochem Pharmacol, 1978.27: 1507-1509.
  • 10Schwartz JC, Lampart C, Rose C. Histamine formation in rat brain in vivo: effects of histidine loads. J Neurochem, 1972,19: 801-810.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部